By improving blood supply to damaged tissue, the peptide helps deliver oxygen, nutrients, and healing factors that would otherwise struggle to reach poorly vascularized structures like the plantar fascia
In 2024, 95% of adverse events associated with GLP-1s were related to either how the product was dosed or how it was administered, rather than issues with the drug
Gormsen LC, Host C, Hjerrild BE, Pedersen SB, Nielsen S, Christiansen JS, Gravholt CH
Dihexa peptide is currently not widely available as it is still under investigation and pending approval through clinical trials
Patients who do not respond after several months of conservative treatment, or whose anatomy clearly will not improve without decompression, are candidates for the MILD procedure or surgery
Is Peptide Therapy Safe and FDA Approved